A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma ...
Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...
A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically reprogramming their gene activity. Credit: Shutterstock Cancer cells may “learn ...
A team of researchers from Brown University Health and Brown University has uncovered an important clue in the fight against ...
Published in Nature Reviews Clinical Oncology, the review brings together global expertise to map the future of meningioma ...
Everyday Health on MSN
First-line treatment options for advanced urothelial carcinoma
First-line treatment for advanced urothelial carcinoma has evolved in recent years from traditional chemotherapy to targeted immunotherapy drugs enfortumab vedotin (Padcev) and pembrolizumab (Keytruda ...
1don MSN
Inside tumors, immune cells hide a split personality—and one side could quietly decide cancer's fate
Macrophages, key regulators of tissue health and immune defense, are among the most abundant immune cells in solid tumors. Their role in cancer has been difficult to define because even closely ...
Learn how new research of the traces life-saving pediatric cancer treatments leave in DNA could help improve the detection ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...
Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results